Influenza vaccinations

Injectable influenza vaccines

The influenza vaccines used in Finland contain components from three strains of viruses. The viruses for the vaccine have been grown in fertilised eggs, then purified, split and inactivated with formaldehyde. More information on the vaccines are available in the package leaflets, which can be found (in Finnish) in the FimeaWeb service.

The vaccines contain only parts of viruses, rather than whole ones. The vaccine will not give you influenza. The seasonal influenza vaccines included in the general vaccination programme contain no preservatives and no adjuvants to enhance the immune response.

The trade names of the injectable influenza vaccines supplied by the National Institute for Health and Welfare (THL) for the season 2017–2018 for all beginning from 6 months of age are Influvac and Agrippal. This recommendation has been issued by the national vaccine specialist group and THL.

Virus strains

The virus strains used in the vaccines are annually determined by the World Health Organization (WHO) and approved by the European Medicines Agency (EMA).

The virus strains used for season 2017-2018 injectable influenza vaccine Influvac and Agrippal are:

  • A/Michigan/45/2015 (H1N1)pdm09-like virus
  • A/Hong Kong/4804/2014 (H3N2) –like virus
  • B/Brisbane/60/2008 -like virus (Victoria-lineage)

Since last season, one virus strain (H1N1) has been replaced. The vaccine will also protect against the swine influenza.

Nasal spray vaccination

As part of the national vaccination programme, children aged 24 - 35 months may be given the Fluenz Tetra nasal spray instead of the injectable vaccine.

The virus strains in Fluenz Tetra in the 2017–2018 season are:

  • A/Michigan/45/2015 (H1N1)pdm09 -like virus strain
  • A/Hong Kong/4801/2014 (H3N2) -like virus strain
  • B/Phuket/3073/2013 -like virus strain (Yamagata lineage)
  • B/Brisbane/60/2008 -like virus strain (Victoria lineage)

The spray differs from the injection in that it contains two different influenza B virus strains and live attenuated viruses. The viruses in the vaccine have been weakened so that the vaccine cannot cause the influenza. When a person is given the vaccine, the immune system (the body's natural defence system) will produce its own protection against the influenza virus. The vaccine does not protect against common cold.

Prescription vaccinations are available under several different trade names in pharmacies. The virus strains in all of them meet the international recommendations, which are updated annually.

More information about influenza, vaccinations and the recommendations included in the national vaccination programme is available on the National Institute for Health and Welfare (THL) website.  For the best coverage of the worldwide situation, please visit the WHO website.

Private persons should contact a local health-care center or private medical clinic for questions regarding their health issues.

Further information

  • Asikainen Tiina
    Senior Medical Officer tel. +358295223314